{"id":"W2800924304","doi":"10.1212/wnl.0000000000005347","title":"Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"MedDay Pharmaceuticals","keywords":"Natalizumab; Medicine; Fingolimod; Guideline; Rituximab; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Systematic review; MEDLINE; Neurology; Intensive care medicine; Family medicine; Psychiatry; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02342124,0.002678051,0.003585012,0.007413386,0.002020958,0.003609624,0.007825246,0.01154504,0.01112957],"category_scores_gemma":[0.09290214,0.001694107,0.009632802,0.006413762,0.00124934,0.004130338,0.003815493,0.01133577,0.007257317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008382629,"about_ca_system_score_gemma":0.03393674,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03172502,"about_ca_topic_score_gemma":0.03830448,"domain_scores_codex":[0.9711563,0.0144457,0.007198175,0.001163492,0.005070631,0.0009656653],"domain_scores_gemma":[0.9400259,0.02085241,0.009428099,0.001105517,0.02635103,0.00223703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001898378,0.0001938068,0.001590233,0.05562758,0.001125852,0.0004163339,0.0009726178,0.001612887,0.0003675581,0.00509418,0.7099441,0.222865],"study_design_scores_gemma":[0.00129894,0.0002047144,0.005337413,0.2506074,0.003588742,0.0007755856,0.0007901296,0.001252322,0.0004649746,0.01156795,0.7239048,0.0002070084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.003708288,0.2358958,0.03470189,0.5631587,0.02462132,0.02908984,0.03987803,0.001328249,0.06761799],"genre_scores_gemma":[0.02649271,0.3008814,0.3573233,0.1844299,0.005538216,0.05353665,0.04845648,0.0004257172,0.0229156],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.03172502,"threshold_uncertainty_score":0.1238648,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0897258710573005,"score_gpt":0.3628580290425424,"score_spread":0.2731321579852419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}